21. Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi. Issue 1 (January 2014) Authors: Merli, Francesco; Luminari, Stefano; Rossi, Giuseppe; Mammi, Caterina; Marcheselli, Luigi; Ferrari, Angela; Spina, Michele; Tucci, Alessandra; Stelitano, Caterina; Capodanno, Isabella; Fragasso, Alberto; Baldini, Luca; Bottelli, Chiara; Montechiarello, Elisa; Fogazzi, Stefano; Lamorgese, Cinzia; ... Journal: Leukemia & lymphoma Issue: Volume 55:Issue 1(2014:Jan.) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study. Issue 4 (30th May 2022) Authors: Durmo, Rexhep; Donati, Benedetta; Rebaud, Louis; Cottereau, Anne Segolene; Ruffini, Alessia; Nizzoli, Maria Elena; Ciavarella, Sabino; Vegliante, Maria Carmela; Nioche, Christophe; Meignan, Michel; Merli, Francesco; Versari, Annibale; Ciarrocchi, Alessia; Buvat, Irene; Luminari, Stefano Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (FIL). (13th January 2016) Authors: Zallio, Francesco; Tamiazzo, Stefania; Monagheddu, Chiara; Merli, Francesco; Ilariucci, Fiorella; Stelitano, Caterina; Liberati, Anna Marina; Mannina, Donato; Vitolo, Umberto; Angelucci, Emanuele; Rota Scalabrini, Delia; Vallisa, Daniele; Bellei, Monica; Bari, Alessia; Ciccone, Giovannino; Salvi,... Journal: British journal of haematology Issue: Volume 172:Number 6(2016) Page Start: 879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy. Issue 4 (21st March 2021) Authors: Di Rocco, Alice; Cuneo, Antonio; Di Rocco, Arianna; Merli, Francesco; De Luca, Giulia; Petrucci, Luigi; Ansuinelli, Michela; Penna, Domenico; Rotondo, Francesco; Rigolin, Gian Matteo; Giaimo, Mariateresa; Re, Francesca; Farcomeni, Alessio; Martelli, Maurizio; Foà, Robin Journal: Leukemia & lymphoma Issue: Volume 62:Issue 4(2021) Page Start: 828 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma. Issue 5 (18th March 2021) Authors: Maurer, Matthew J.; Jakobsen, Lasse H.; Mwangi, Raphael; Schmitz, Norbert; Farooq, Umar; Flowers, Cristopher R.; de Nully Brown, Peter; Thompson, Carrie A.; Frederiksen, Henrik; Cunningham, David; Jørgensen, Judit; Poeschel, Viola; Nowakowski, Grzegorz; Seymour, John F.; Merli, Francesco; Haioun,... Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Resveratrol‐mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation. Issue 5 (7th August 2012) Authors: Frazzi, Raffaele; Valli, Riccardo; Tamagnini, Ione; Casali, Bruno; Latruffe, Norbert; Merli, Francesco Journal: International journal of cancer Issue: Volume 132:Issue 5(2013:Mar. 01) Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients. Issue 1 (12th November 2016) Authors: Polverelli, Nicola; Breccia, Massimo; Benevolo, Giulia; Martino, Bruno; Tieghi, Alessia; Latagliata, Roberto; Sabattini, Elena; Riminucci, Mara; Godio, Laura; Catani, Lucia; Nicolosi, Maura; Perricone, Margherita; Sollazzo, Daria; Colafigli, Gioia; Campana, Anna; Merli, Francesco; Vitolo, Umberto... Journal: American journal of hematology Issue: Volume 92:Issue 1(2017:Jan.) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study. Issue 12 (2nd December 2015) Authors: Iannitto, Emilio; Luminari, Stefano; Tripodo, Claudio; Mancuso, Salvatrice; Cesaretti, Marina; Marcheselli, Luigi; Merli, Francesco; Stelitano, Caterina; Carella, Angelo Michele; Fragasso, Alberto; Montechiarello, Elisa; Ricciuti, Giuseppina; Pulsoni, Alessandro; Paulli, Marco; Franco, Vito; Fede... Journal: Leukemia & lymphoma Issue: Volume 56:Issue 12(2015:Dec.) Page Start: 3281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study. Issue 8 (August 2017) Authors: Chiappella, Annalisa; Martelli, Maurizio; Angelucci, Emanuele; Brusamolino, Ercole; Evangelista, Andrea; Carella, Angelo Michele; Stelitano, Caterina; Rossi, Giuseppe; Balzarotti, Monica; Merli, Francesco; Gaidano, Gianluca; Pavone, Vincenzo; Rigacci, Luigi; Zaja, Francesco; D'Arco, Alfonso; Casc... Journal: Lancet oncology Issue: Volume 18:Issue 8(2017:Aug.) Page Start: 1076 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. Issue 4 (4th April 2023) Authors: Gotti, Manuel; Sciarra, Roberta; Pulsoni, Alessandro; Merli, Francesco; Luminari, Stefano; Zerbi, Caterina; Trentin, Livio; Re, Alessandro; Rusconi, Chiara; Viviani, Simonetta; Rossi, Andrea; Cocito, Federica; Botto, Barbara; Meli, Erika; Pinto, Antonello; Dogliotti, Irene; Gini, Guido; Puccini, ... Journal: HemaSphere Issue: Volume 7:Issue 4(2023) Page Start: e837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗